Italy Stop AstraZeneca vaccine for under-60s after youngster dies

After the death of an adolescent who took the injection, the Government announced Friday that the use of the AstraZeneca COVID-19 vaccination was restricted to persons over 60.

After being vaccinated on Thursday, 25 May, Camilla Canepa died. In Italy, despite medical concerns voiced, a storm of controversy was caused by the Anglo-Swedish brands supplied to adults of all ages.

The special COVID commissioner Francesco Figliuolo informed reporters during the news meeting, "Astra Zeneca would be used solely for persons over 60."

Another unusual blood disease was detected earlier in the day as a potential adverse effect of the AstraZeneca COVID-19 vaccine. The European pharma agency reported investigating cases of cardiovascular inflammations following all coronavirus inoculations.

The European Medicines Agency (EMA) safety committee recommended that a new adverse effect for labelled vaccination called Vaxzevria should be added to capillary leak condition.

EmA said that those who have previously endured this disease should not receive a shot when fluids leak from the tiniest blood vessels producing oedema and decreased blood pressure.

Post a Comment

Please do not enter any spam link in the comment box.